drugset
drugset / Trial / NCT05102266

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy Volunteers

NCT05102266 ↗

Phase 1 Completed 60 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the pharmacokinetic properties and safety of "BR1016C" and "BR1016D" in healthy adults.

Timeline

Start
2021-10-27
Primary completion
2021-12-18
Completion
2021-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1016C Unknown — Oral
Subject BR1016D Unknown — Oral

Indications

heart failure